NW CORPORATE RESULTS | Dollar figures in thousands, except per share; parentheses denote losses. Targeted Genetics Biotechnology Dec. 31 % 4th QTR...

Share story

Dollar figures in thousands, except per share; parentheses denote losses.

Targeted Genetics
Biotechnology
Dec. 31 %
4th QTR 2007 2006 CHG
Profit ($5,073) $808
Per share (0.26) 0.08
Revenue 3,220 4,008 -19.7
ANNUAL 2007 2006 CHG
Profit ($16,127) ($33,990) +52.6
Per share (0.98) (3.47) +71.8
Revenue 10,332 9,864 +4.7
COMMENT: The Seattle biotech firm swung to a quarterly loss on higher research-and-development expenses.